Drug company sponsorship of academic conferences unpopular? Doctors want to clean up the academic conference environment!
A few days ago, in Shijiazhuang, Hebei Province, Taixing State Hotel held the "Third Academic Conference on Pancreatic Diseases in Hebei Province and Digestive and Gastrointestinal Endoscopy Standard Diagnosis and Treatment Seminar" (hereinafter referred to as the seminar), not only the whole process is full of drug advertising, the organizers are openly for a drug "stand", to many primary care doctors to preach the efficacy of a drug, the seriousness of the meeting was questioned by many participating doctors.
The reporter found that drug companies and pharmaceutical companies sponsor medical conferences in China has become the norm. In order to regulate the practice of doctors and academic exchange behavior, the former National Health Planning Commission and the Chinese Medicine Administration jointly developed and released the "Strengthening the construction of medical and health care practices "nine no"", a number of provinces have introduced relevant measures, but many medical academic conference and drug companies, drug companies between the relationship is still "ambiguous ". In this regard, many doctors expressed the hope that the environment of academic conferences can be purified.
Looking for chemical products? Let suppliers reach out to you!
2026-06-29
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
What do pharmaceutical companies look forin the rare disease field?
-
What Are The Top Selling Generic Drugs In 2018?
-
24.6 Down To $0.84! A Batch Of Reduced-Price Drugs Are Now Available In Pharmacies
-
China Small Molecule Innovative Drugs Industry Trends to 2022
-
FDA approves Merck's new drug Belzutifan
-
Active R&D and strong demand for innovative peptide drugs
-
Anxious drug company bosses pile on innovative drugs
-
Children's medicine 'legalization' to accelerate the layout of drug companies
-
Original drug market: The prices of upstream raw materials remain high, and downstream small businesses are under great pressure to survive!
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
Recommend Reading
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Novo Nordisk Faces a Compliance Test
-
India’s API Trade Balance Turns Positive
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
BioNTech’s Founders Turn the Page
-
Multiple Positive Factors Support a Rise in the Butadiene Market
-
Double Benefits: Aniline Market Rises Multiple Times
-
Rise in Chinese Urea Market Prices (1.12-1.16)
-
Construction Start Boosts Costs; January Isooctanol Prices Show Volatile Rise
-
This week, caustic soda prices showed a weak trend (1.12-1.16)